Publication
Number of items: 25.
5 December 2020
  • Dysregulation of TRPV4, eNOS and caveolin-1 contribute to endothelial dysfunction in the streptozotocin rat model of diabetes. (2020) Yousif Shamsaldeen, Lisa Lione and Christopher Benham
    • 5 January 2019
  • Dysfunction in nitric oxide synthesis in streptozotocin treated rat aorta and role of methylglyoxal. (2019) Yousif Shamsaldeen, Mahdi Alsugoor, Lisa Lione and Christopher Benham
    • 15 October 2014
  • The H3 receptor agonist immepip does not affect l-dopa-induced abnormal involuntary movements in 6-OHDA-lesioned rats. (2014) Maria Papathanou, Peter Jenner, Mahmoud M. Iravani, Michael Jackson, Kim Stockwell, Isobel Strang, Bai-Yun Zeng, Andrew McCreary and Sarah Rose
    • 2007
  • Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl) thiophene (DuP-697). (2007) A. Churchman, A. R. Baydoun and R. Hoffman
    • 2006
  • Cannabinoid signalling in TNF-alpha induced IL-8 release. (2006) M. E. Mormina, S. Thakur, A. Molleman, C.J. Whelan and A. R. Baydoun
    • 2005
  • The responses to manipulation of extracellular and intracellular calcium are altered in the streptozotocin-diabetic rat colon and ileum. (2005) A. Forrest, A. Molleman and M. Parsons
    • 15 December 2004
  • Not so EEZE : the ‘EDHF’ antagonist 14, 15 Epoxyeicosa-5(z)-enoic Acid has vasodilator properties in mesenteric arteries. (2004) Louise Susan MacKenzie, John R. Falck and Jane A. Mitchell
    • 2003
  • Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells. (2003) K. Ihenetu, A. Molleman, M. Parsons and C.J. Whelan
  • Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids. (2003) K. Ihenetu, A. Molleman, M. Parsons and C.J. Whelan
  • Streptozotocin-induced diabetes modulates presynaptic and postsynaptic function in the rat ileum. (2003) C. Talubmook, A. Forrest and M. Parsons
    • 2002
  • Modulation of the release of endogenous gamma-aminobutyric acid by cannabinoids in the guinea pig ileum. (2002) M. Begg, A. Molleman and M. Parsons
    • 19 January 2001
  • Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets. (2001) S. Costa, Mahmoud M. Iravani, R. K. B. Pearce and P. Jenner
    • 31 March 2000
  • The role of fractalkine in the recruitment of monocytes to the endothelium. (2000) Gayle A. Chapman, Kitty E. Moores, Jayneeta Gohil, Theo Berkhout, Lisa Patel, Paula Green, Colin H. MacPhee and Brian R. Stewart
    • 2000
  • Rank-order inhibition by ω-conotoxins in human and animal autonomic nerve preparations. (2000) G. Sanger, E.S. Ellis, M. Harries, N.S. Tilford, K.A. Wardle and C.D. Benham
  • Characterisation of SB-221420-A, a neuronal Ca and Na channel antagonist in experimental models of stroke. (2000) C.A. Campbell, F.C. Barone, C.D. Benham, S.J. Hadingham, M. Harries, J.M. Hills, V.A. Lewis, A.A. Parsons, R.F. White and A.J. Hunter
    • July 1998
  • Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain : a selective ligand for imidazoline I2 receptors. (1998) Lisa Lione, D.J. Nutt and A.L. Hudson
    • 29 October 1997
  • The presence and the effects of neuropeptide Y in rat anococcygeus muscle. (1997) Mahmoud M. Iravani and M. A. Zar
    • May 1996
  • [3H]2-(2-Benzofuranyl)-2-imidazoline : a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors. (1996) Lisa Lione, D.J. Nutt and A.L. Hudson
    • 3 March 1994
  • Pharmacodynamics of tolfenamic acid in dogs : Evaluation of dose response relationships. (1994) Quintin McKellar, P. Lees and G. Gettinby
    • 30 November 1993
  • Differential-effects of Nifedipine on nerve-mediated and noradrenaline-evoked contractions of rat anococcygeus muscle. (1993) Mahmoud M. Iravani and M. A. Zar
    • 1990
  • α-Adrenoceptor regulation of inositol phosphates, internal calcium and membrane current in DDT1 MF-2 smooth muscle cells. (1990) A. Nelemans, B. Hoiting, A. Molleman, M. Duin and A. Denhertog
  • Characteristics of the P2-Purinoceptor- receptor and H1-receptor mediated response in DDT1 MF-2 vas deferens smooth muscle cells. (1990) A. Molleman, B. Hoiting, J. Vandenakker, M. Duin, A. Nelemans and A. Denhertog
  • P2-Purinoceptor-activated membrane currents and inositol tetrakisphosphate formation are blocked by suramin. (1990) B. Hoiting, A. Molleman, A. Nelemans and A. Denhertog
  • P2 –Purinoceptor-mediated inositol phosphate formation in relation to cytoplasmic calcium in DDT1 MF-2 smooth muscle cells. (1990) B. Hoiting, A. Molleman, M. Duin, A. Denhertog and A. Nelemans
    • 1989
  • P2 –Purinoceptor-mediated membrane currents in DDT1 MF-2 smooth muscle cells. (1989) A. Molleman, A. Nelemans and A. Denhertog